Sumary of No change in asthma medication use after transition to high-deductible health plan:
- Galbraith reports she received grants from the Agency for Healthcare Research and Quality, Harvard Pilgrim Health Care and Patient-Centered Outcomes Research Institute..
- Transition to a high-deductible health plan that largely exempted medications from the deductible was associated with minimal or no change in use of asthma controllers and exacerbations among children and adults with persistent asthma..
- “Evidence about high-deductible health plans comes mostly from adult-focused studies and whether these findings can be applied to children is unclear,”.
- Galbraith, MD, MPH, associate professor in the department of population medicine at Harvard Pilgrim Health Care Institute at Harvard Medical School, and colleagues wrote in JAMA Pediatrics..
- The primary outcome was 30-day fill rates and medication adherence for asthma controller medications, which included inhaled corticosteroids (ICS), leukotriene inhibitors and ICS-long-acting beta agonists..
- The researchers reported significant decreases in annual 30-day fill rates for ICS-LABA medications in children who switched to high-deductible health plans compared with the control group (absolute change, –0.04;.
- However, there were no significant reductions in 30-day fill rates for any asthma controller medications in adults who switched to high-deductible health plans….